342 related articles for article (PubMed ID: 17381426)
1. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.
Spite M; Baba SP; Ahmed Y; Barski OA; Nijhawan K; Petrash JM; Bhatnagar A; Srivastava S
Biochem J; 2007 Jul; 405(1):95-105. PubMed ID: 17381426
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase-catalyzed reduction of aldehyde phospholipids.
Srivastava S; Spite M; Trent JO; West MB; Ahmed Y; Bhatnagar A
J Biol Chem; 2004 Dec; 279(51):53395-406. PubMed ID: 15465833
[TBL] [Abstract][Full Text] [Related]
3. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
4. Involvement of aldose reductase in the metabolism of atherogenic aldehydes.
Srivastava S; Liu SQ; Conklin DJ; Zacarias A; Srivastava SK; Bhatnagar A
Chem Biol Interact; 2001 Jan; 130-132(1-3):563-71. PubMed ID: 11306075
[TBL] [Abstract][Full Text] [Related]
5. Structural and kinetic determinants of aldehyde reduction by aldose reductase.
Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A
Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881
[TBL] [Abstract][Full Text] [Related]
6. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.
Ruiz FX; Moro A; Gallego O; Ardèvol A; Rovira C; Petrash JM; Parés X; Farrés J
Chem Biol Interact; 2011 May; 191(1-3):199-205. PubMed ID: 21329680
[TBL] [Abstract][Full Text] [Related]
7. Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds.
Shen Y; Zhong L; Johnson S; Cao D
Chem Biol Interact; 2011 May; 191(1-3):192-8. PubMed ID: 21329684
[TBL] [Abstract][Full Text] [Related]
8. The aldo-keto reductases (AKRs): Overview.
Penning TM
Chem Biol Interact; 2015 Jun; 234():236-46. PubMed ID: 25304492
[TBL] [Abstract][Full Text] [Related]
9. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.
Joshi A; Rajput S; Wang C; Ma J; Cao D
Biol Chem; 2010 Dec; 391(12):1371-8. PubMed ID: 21087085
[TBL] [Abstract][Full Text] [Related]
10. Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.
Vladykovskaya E; Ozhegov E; Hoetker JD; Xie Z; Ahmed Y; Suttles J; Srivastava S; Bhatnagar A; Barski OA
J Lipid Res; 2011 Dec; 52(12):2209-2225. PubMed ID: 21957201
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of four rabbit aldo-keto reductases featuring broad substrate specificity for xenobiotic and endogenous carbonyl compounds: relationship with multiple forms of drug ketone reductases.
Endo S; Matsunaga T; Arai Y; Ikari A; Tajima K; El-Kabbani O; Yamano S; Hara A; Kitade Y
Drug Metab Dispos; 2014 Apr; 42(4):803-12. PubMed ID: 24510382
[TBL] [Abstract][Full Text] [Related]
12. A pathogenesis related-10 protein CaARP functions as aldo/keto reductase to scavenge cytotoxic aldehydes.
Jain D; Khandal H; Khurana JP; Chattopadhyay D
Plant Mol Biol; 2016 Jan; 90(1-2):171-87. PubMed ID: 26577640
[TBL] [Abstract][Full Text] [Related]
13. Novel Aldo-Keto Reductases for the Biocatalytic Conversion of 3-Hydroxybutanal to 1,3-Butanediol: Structural and Biochemical Studies.
Kim T; Flick R; Brunzelle J; Singer A; Evdokimova E; Brown G; Joo JC; Minasov GA; Anderson WF; Mahadevan R; Savchenko A; Yakunin AF
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28130301
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7.
Kabututu Z; Manin M; Pointud JC; Maruyama T; Nagata N; Lambert S; Lefrançois-Martinez AM; Martinez A; Urade Y
J Biochem; 2009 Feb; 145(2):161-8. PubMed ID: 19010934
[TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.
Endo S; Matsunaga T; Mamiya H; Ohta C; Soda M; Kitade Y; Tajima K; Zhao HT; El-Kabbani O; Hara A
Arch Biochem Biophys; 2009 Jul; 487(1):1-9. PubMed ID: 19464995
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rabbit aldose reductase-like protein with 3β-hydroxysteroid dehydrogenase activity.
Endo S; Matsunaga T; Kumada S; Fujimoto A; Ohno S; El-Kabbani O; Hu D; Toyooka N; Mano J; Tajima K; Hara A
Arch Biochem Biophys; 2012 Nov; 527(1):23-30. PubMed ID: 22874434
[TBL] [Abstract][Full Text] [Related]
17. A new nomenclature for the aldo-keto reductase superfamily.
Jez JM; Flynn TG; Penning TM
Biochem Pharmacol; 1997 Sep; 54(6):639-47. PubMed ID: 9310340
[TBL] [Abstract][Full Text] [Related]
18. Characterization of AKR4C15, a Novel Member of Aldo-Keto Reductase, in Comparison with Other Rice AKR(s).
Auiyawong B; Narawongsanont R; Tantitadapitak C
Protein J; 2017 Aug; 36(4):257-269. PubMed ID: 28699078
[TBL] [Abstract][Full Text] [Related]
19. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211
[TBL] [Abstract][Full Text] [Related]
20. Catalytic reduction of carbonyl groups in oxidized PAPC by Kvβ2 (AKR6).
Xie Z; Barski OA; Cai J; Bhatnagar A; Tipparaju SM
Chem Biol Interact; 2011 May; 191(1-3):255-60. PubMed ID: 21296056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]